Cencora, Inc.
COR
#402
Rank
$62.551 B
Marketcap
United States
Country
$327.79
Share price
-1.82%
Change (1 day)
9.51%
Change (1 year)
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical…
Key Metrics
Trailing P/E
23.15
Forward P/E
15.75
EPS (TTM)
$13.47
Forward EPS
$19.81
Price / Book
19.51
EV / EBITDA
13.1x
Beta
0.57
Dividend Yield
0.75%
Return on Equity
96.87%
Return on Assets
3.56%
Debt / Equity
446.52
Current Ratio
0.94
Gross Margin
3.96%
Operating Margin
1.41%
Net Profit Margin
0.79%
Free Cash Flow
$2.043B
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 18 – Sep 17
-1.35%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$321.333B
Latest Net Income$1.554B
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare Cencora, Inc. with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
COR
No recent news available. Set FINNHUB_API_KEY to enable news.
